Skip to main content
Premium Trial:

Request an Annual Quote

Microsoft Tapped to Provide Cloud Compute, Support for TeraDiscoveries Drug Research


TeraDiscoveries and Microsoft this week announced a partnership under which Microsoft will provide support and cloud computing time on its Windows Azure platform, which TeraDiscoveries will use to identify inhibitors of 25 biological targets.

Specifically, TeraDiscoveries will use its Inverse Design computational modeling software running on the Azure platform to mine virtual chemical libraries to find the strongest inhibitors of specific biological targets that have good clinical trial properties and have a low probability of toxic side effects, the company said.

Ed Addison, TeraDiscoveries CEO, said in statement that the partnership with Microsoft provides a more efficient and cost-effective approach for searching the chemical space than traditional methods offer.

He added that the arrangement will enable the company to forge partnerships with smaller pharmaceutical or medical research companies who are interested in further developing these molecules.

These companies can purchase licenses to Inverse Design and run it on Azure as part of their efforts to design, discover, or optimize new small molecule or peptide drugs for their targets, TeraDiscoveries said. The company also offers drug discovery services.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.